Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 0 | 0 |
% | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company is mainly engaged in supplying third party products in organic/inorganic chemicals, bulk drugs, food chemicals, Pharmaceuticals, etc. It marked drastic de-growth in its top lines for the reported periods, but net margin surged from FY24 onwards that raise eyebrows and concern over its sustainability going forward as it is operating in a highly competitive and fragmented segment. Higher spending for IPO process hints at structured and managed funding. Small equity base post-IPO indicates longer gestation for migration. Based on its recent super earnings, the issue appears aggressively priced. There is no harm in skipping this “High Risk/Low Return” bet. Read detail review...
Citichem India Limited peer comparison with similar listed entities. (As on March 28, 2024)
Company Name | EPS (Basic) | EPS (Diluted) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
---|---|---|---|---|---|---|
Citichem India Limited | 2.24 | 2.24 | 31.3 | 15.42 | 14.5 | |
Shankar Lal Rampal Dye-chem Ltd | 1.02 | 1.02 | 91.33 | 6.59 | 15.4 | |
Vinyl Chemicals (india) Ltd. | 11.91 | 11.91 | 30.31 | 18.71 | 63.66 |
Financial information for the Company is derived from Restated Financial Statements of our Company for the year ended March 31, 2024.
Source: All the financial information for listed industry peer mentioned is sourced from the annual report of the relevant companies for Fiscal 2024, as available on the websites of the Stock Exchanges.
Notes for peer group:
Citichem India IPO Reviews, analysis and views by popular members. Read Citichem India Ltd. IPO reviews by retail investors to find recommended ipo to buy.
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 0 | 0 |
% | 0.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
No recommendation found. Be the first to post the recommendation. |
Note: